First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
To accelerate the development of next-generation radioconjugates to treat cancer
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
Subscribe To Our Newsletter & Stay Updated